openPR Logo
Press release

Postpartum Depression Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Sage Therapeutics

01-06-2025 05:17 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Postpartum Depression Pipeline Insights 2024

Postpartum Depression Pipeline Insights 2024

Postpartum Depression Pipeline constitutes 2+ key companies continuously working towards developing 2+ Postpartum Depression treatment therapies, analyzes DelveInsight.

Postpartum Depression Overview:

The arrival of a baby can evoke a range of intense emotions, from excitement and happiness to fear and anxiety. Many new mothers experience the "baby blues" after childbirth, which often include mood swings, crying, anxiety, and trouble sleeping. These symptoms typically begin within two to three days after delivery and can last up to two weeks. However, some mothers may develop a more severe and prolonged form of depression known as postpartum depression. In rare cases, a serious mood disorder called postpartum psychosis may also occur. Postpartum depression is not a sign of weakness or a personal failing; it is often simply a complication of childbirth.

"Postpartum Depression Pipeline Insight 2024" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Postpartum Depression Therapeutics Market.

Request for a postpartum depression pipeline sample report @ https://www.delveinsight.com/report-store/postpartum-depression-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Key Takeaways from the Postpartum Depression Pipeline Report

DelveInsight's Postpartum Depression pipeline report depicts a robust space with 2+ active players working to develop 2+ pipeline therapies for Postpartum Depression treatment.
Key Postpartum Depression companies such as Sage Therapeutics, and others are evaluating new drugs for Postpartum Depression to improve the treatment landscape.
Promising Postpartum Depression pipeline therapies in various stages of development include Zuranolone, and others.

Postpartum Depression Pipeline Analysis
The report provides insights into:
The report provides detailed insights into the key companies that are developing therapies in the Postpartum Depression Market.
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Postpartum Depression treatment.
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Postpartum Depression market.

Request for detailed insights into our postpartum depression pipeline insights report @ https://www.delveinsight.com/report-store/postpartum-depression-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Postpartum Depression Companies

There are around two key companies developing therapies for postpartum depression. Among them, Sage Therapeutics and others have drug candidates for postpartum depression in the mid to advanced stages, specifically Phase III.

DelveInsight's report covers around 22+ products under different phases of clinical development like

Late stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I) along with the details of
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates

Postpartum Depression pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

Intravenous
Subcutaneous
Oral
Intramuscular

Postpartum Depression Products have been categorized under various Molecule types such as

Monoclonal antibody
Small molecule
Peptide

Download Sample Pages to Get an in-depth Assessment of the Emerging Postpartum Depression Therapies and Key Companies: Postpartum Depression Clinical Trials and advancements @ https://www.delveinsight.com/sample-request/postpartum-depression-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Postpartum Depression Pipeline Therapeutic Assessment
• Postpartum Depression Assessment by Product Type
• Postpartum Depression By Stage
• Postpartum Depression Assessment by Route of Administration
• Postpartum Depression Assessment by Molecule Type

Download Postpartum Depression Sample report to know in detail about the Postpartum Depression treatment market @ https://www.delveinsight.com/sample-request/postpartum-depression-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Table of Content

1. Report Introduction
2. Executive Summary
3. Postpartum Depression Current Treatment Patterns
4. Postpartum Depression - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Postpartum Depression Late-Stage Products (Phase-III)
7. Postpartum Depression Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Postpartum Depression Discontinued Products
13. Postpartum Depression Product Profiles
14. Postpartum Depression Key Companies
15. Postpartum Depression Key Products
16. Dormant and Discontinued Products
17. Postpartum Depression Unmet Needs
18. Postpartum Depression Future Perspectives
19. Postpartum Depression Analyst Review
20. Appendix
21. Report Methodology

Request the Sample PDF to Get Detailed Insights About the Postpartum Depression Pipeline Reports Offerings: https://www.delveinsight.com/sample-request/postpartum-depression-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Contact Info:
Kritika Rehani
krehani@delveinsight.com
info@delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Postpartum Depression Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Sage Therapeutics here

News-ID: 3804916 • Views:

More Releases from DelveInsight Business Research LLP

Gonorrhoea Pipeline Outlook Report 2025: MOA, Companies, Companies, Clinical Trials, Expanding Therapeutic Classes, and Future Market Impact Revealed
Gonorrhoea Pipeline Outlook Report 2025: MOA, Companies, Companies, Clinical Tri …
DelveInsight's "Gonorrhoea Pipeline Insight 2025" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Gonorrhoea pipeline landscape. It covers the Gonorrhoea pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Gonorrhoea pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Gonorrhoea pipeline products in this space. Explore our latest breakthroughs in Gonorrhoea Research. Learn
Glioblastoma Multiforme Market Size (7MM) was ~USD 835 million in 2023 and is expected to increase with a significant CAGR by 2034, estimates DelveInsight | Novocure, Roche (Genentech), Merck, Daiichi Sankyo, Novartis, Bayer, Aivita Biomedical and TAE Lif
Glioblastoma Multiforme Market Size (7MM) was ~USD 835 million in 2023 and is ex …
DelveInsight's "Glioblastoma Multiforme Market Insight, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of GBM, historical and forecasted epidemiology as well as the GBM market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Discover Key Insights into the Glioblastoma Multiforme Market with DelveInsight's In-Depth Report @ Glioblastoma Multiforme Market Size- https://www.delveinsight.com/sample-request/glioblastoma-multiforme-gbm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Glioblastoma Multiforme Market Report • In
Blepharitis Treatment Market Size in the 7MM is expected to grow by 2034, estimates DelveInsight | Tarsus Pharmaceuticals Inc., LianBio LLC, Nicox Ophthalmics Inc., Eye Research Foundation Inc., Laboratoires Thea, Sun Pharmaceutical Industries Limited, Me
Blepharitis Treatment Market Size in the 7MM is expected to grow by 2034, estima …
DelveInsight's "Blepharitis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Blepharitis, historical and forecasted epidemiology, as well as the Blepharitis market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Explore the intricate details of the Blepharitis Market: Uncover drug uptake, treatment dynamics, and epidemiological trends with our comprehensive Blepharitis Market Forecast @ https://www.delveinsight.com/sample-request/blepharitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from
CAR-T in NHL Treatment Market Size is estimated to grow by 2034, estimates DelveInsight | Allogene Therapeutics, Novartis, Miltenyi Biomedicine, Mustang Bio, CRISPR Therapeutics, 2seventy bio, Imugene
CAR-T in NHL Treatment Market Size is estimated to grow by 2034, estimates Delve …
DelveInsight's "CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of CAR T-Cell Therapy for Non-Hodgkin's Lymphoma, historical and forecasted epidemiology, as well as the CAR T-Cell Therapy for Non-Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Explore the intricate details of the CAR T-Cell Therapy for Non-Hodgkin's Lymphoma

All 5 Releases


More Releases for Postpartum

Postpartum Care Services Market 2025-2033
London, UK - September 2025 | Strategic Revenue Insights Inc. The Postpartum Care Services market is rapidly emerging as a critical sector within the global healthcare industry, driven by the increasing focus on maternal health and well-being. As families recognize the importance of comprehensive postpartum support, demand for specialized services such as in-home care, hospital-based care, telehealth, and lactation consulting has surged. Forecasts indicate that the market is poised to
Key Trend Reshaping the Postpartum Depression Market in 2025: Companies Innovati …
What Are the Projections for the Size and Growth Rate of the Postpartum Depression Market? The postpartum depression market has witnessed exponential growth in recent years. It will grow from $12.15 billion in 2024 to $16.09 billion in 2025, at a CAGR of 32.4%. The historic growth can be attributed to increased awareness about maternal mental health, research progress, public health initiatives, and a rise in screenings. The postpartum depression market is
Postpartum Depression Global Market Report 2024 - Postpartum Depression Market S …
The Business Research Company recently released a comprehensive report on the Global Postpartum Depression Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The postpartum depression market
Elevate Your Strategy: Insights on Postpartum Depression Market Potential
𝐆𝐫𝐨𝐰𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬, a renowned Market research firm, introduces its latest research report on the 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭, providing a detailed guide for businesses seeking growth progression. This report is meticulously crafted to aid in investment decisions, offering crucial insights and encouraging strategic investment discretion for new entrants aiming for seamless Market penetration. 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐑𝐞𝐩𝐨𝐫𝐭 https://growthmarketreports.com/request-sample/4187 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐏𝐨𝐬𝐭𝐩𝐚𝐫𝐭𝐮𝐦 𝐃𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭: The global
Postpartum Hemorrhage Treatment Market Trends | 2022 | Industry Analysis
The global postpartum hemorrhage treatment market size was valued at USD 802.34 in 2021, growing at a CAGR of 5.3% during the forecast period 2022-28. During the postpartum hemorrhage surgical operation, postpartum hemorrhage therapy devices are essential medical equipment. The severe blood loss that occurs in the initial few hours following childbirth is known as postpartum hemorrhage, and it can even result in the death of the mother. It is
Demand: Postpartum Hemorrhage Devices Market to Fuel Revenue Growth
The global postpartum hemorrhage devices market is estimated to surpass $1,170.3 million by 2027, exhibiting a CAGR of 5.2% from 2020 to 2027. The report aims to cater scrupulous analysis of the global postpartum hemorrhage devices market by methodically reviewing different facets of the market such as key segments, market dynamics, regional market circumstances, investment opportunities, and top players operating in the market. In addition, the report offers insights on the current